SCIENTIFIC ADVISORY BOARD

This board consists of international experts of translational and clinical research of STS.

Prof. Judith BOVEE

Clinician scientist

Professor Pathology (bone and soft tissue tumors)

Leiden University Medical Center

Netherlands

Prof. Robert MAKI

Sarcoma Oncologist

Early Drug Development Specialist

Memorial Sloan-Kettering Cancer Center

New-York, USA

Prof. Pedro ROMERO

Honorary Professor

Deputy scientific managing director of the Lausanne Branch

Ludwig Institute for Cancer Research

Switzerland

Prof. Zlatko TRAJANOSKI

Professor for Bioinformatics,

Head of the Institute of Bioinformatics at the Biocenter,

Medical University of Innsbruck

Austria

————————————————————

EXECUTIVE COMMITEE

This board consists of the Scientific Coordinator, workpackage and partners’ scientific leaders.

Objectives: Main supervisory body for the project execution, reporting and accountability before the General Assembly of partners. The ExC monitores strategic planning, work progress, identify and resolve problems or delays, ensure quality assurance and control project deliverables, budget, consistent and timely reporting.

CONDOR project wants to revolutionize by 2027 the therapeutic management of soft tissue sarcomas patients with 1 coordinator + 7 strategic partners...

Pr Antoine ITALIANO
Project Coordinator

CONDOR project wants to revolutionize by 2027 the therapeutic management of soft tissue sarcomas patients with 1 coordinator + 7 strategic partners...

Charles MAUSSION
WP2 leader

CONDOR project wants to revolutionize by 2027 the therapeutic management of soft tissue sarcomas patients with 1 coordinator + 7 strategic partners...

Alban BESSEDE
WP3 leader

CONDOR project wants to revolutionize by 2027 the therapeutic management of soft tissue sarcomas patients with 1 coordinator + 7 strategic partners...

Pr Hervé FRIDMAN
WP4 leader

Stephan SCHANN
WP5 leader

Dr Sophie POSTEL-VINAY
Gustave Roussy scientific leader

CONDOR project wants to revolutionize by 2027 the therapeutic management of soft tissue sarcomas patients with 1 coordinator + 7 strategic partners...

Dr Armelle DUFRESNE
Centre Léon Bérard scientific leader

CONDOR project wants to revolutionize by 2027 the therapeutic management of soft tissue sarcomas patients with 1 coordinator + 7 strategic partners...

Dr Helène ESPEROU
INSERM scientific leader

CONDOR project wants to revolutionize by 2027 the therapeutic management of soft tissue sarcomas patients with 1 coordinator + 7 strategic partners...

SUBSCRIBE
TO OUR
NEWSLETTER

MEMBER ACCESS
CONDOR project wants to revolutionize by 2027 the therapeutic management of soft tissue sarcomas patients with 1 coordinator + 7 strategic partners...
MAKE A DONATION